Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1002/jmv.26150

Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?

Research output: Contribution to journal › Letter › peer-review

Abstract

The study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.

Original language	English
Pages (from-to)	92-93
Number of pages	2
Journal	Journal of Medical Virology
Volume	93
Issue number	1
Early online date	10 Jun 2020
DOIs	https://doi.org/10.1002/jmv.26150
Publication status	Published - 1 Jan 2021

Access to Document

10.1002/jmv.26150Licence: Unspecified

Link to publication in Scopus

Cite this

@article{fec12e58978f4fb4b8632959dd546084,

title = "Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?",

abstract = "The study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.",

keywords = "Melatonin, COVID-19, laryngopharyngeal reflux disease",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = jan,

day = "1",

doi = "10.1002/jmv.26150",

language = "English",

volume = "93",

pages = "92--93",

journal = "Journal of Medical Virology",

issn = "0146-6615",